Insider trades
Hunter Gillies, Chief Officer of Jade Biosciences JBIO, has filed 0 purchases and 20 sales on the open market. The latest trade was on 24/06/13.
Hunter Gillies
Chief Medical Officer
- Company
- Jade Biosciences JBIO
- First filing
- 23/02/08
- Trades
- 63 trades
- Buys / sales
- 0 / 20
- 12-month net buying
- No record
- Last trade
- 24/06/13
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
Jade BiosciencesJBIO | Open-market sale10b5-1 plan | 24/06/13 | 24/06/14 | 6,000 sh | $24.50 | $147,000 | −51.7% |
JBIO | Open-market sale10b5-1 plan | 24/05/17 | 24/05/17 | 4,000 sh2 trades | $21.09avg. | $84,347.94 | −41.7% |
JBIO | Open-market sale10b5-1 plan | 24/04/17 | 24/04/19 | 4,000 sh2 trades | $22.38avg. | $89,520.33 | −55.2% |
Jade BiosciencesJBIO | Open-market sale10b5-1 plan | 24/03/28 | 24/04/01 | 9,000 sh | $29.50 | $265,500 | −73.5% |
JBIO | Open-market sale10b5-1 plan | 24/03/18 | 24/03/20 | 7,000 sh2 trades | $25.86avg. | $181,031.67 | −68.3% |
Jade BiosciencesJBIO | Open-market sale10b5-1 plan | 24/03/07 | 24/03/11 | 8,975 sh | $24.50 | $219,887.5 | −73.4% |
Jade BiosciencesJBIO | Open-market sale10b5-1 plan | 24/02/23 | 24/02/27 | 511 sh | $19.50 | $9,964.5 | −13.6% |
JBIO | Open-market sale10b5-1 plan | 24/02/20 | 24/02/22 | 3,489 sh2 trades | $20.23avg. | $70,585.85 | −51.8% |
Jade BiosciencesJBIO | Open-market sale10b5-1 plan | 24/01/17 | 24/01/19 | 4,000 sh | $19.50 | $78,000 | −55.2% |
Jade BiosciencesJBIO | Open-market sale10b5-1 plan | 23/12/27 | 23/12/29 | 125 sh | $24.50 | $3,062.5 | −3.7% |
Jade BiosciencesJBIO | Open-market sale10b5-1 plan | 23/12/20 | 23/12/22 | 4,000 sh | $19.50 | $78,000 | −55.2% |
JBIO | Open-market sale10b5-1 plan | 23/12/13–23/12/14 | 23/12/15 | 12,000 sh2 trades | $19.50avg. | $234,000 | −78.7% |
Jade BiosciencesJBIO | Open-market sale10b5-1 plan | 23/05/19 | 23/05/23 | 65 sh | $19.50 | $1,267.5 | −2.0% |
Jade BiosciencesJBIO | Open-market sale10b5-1 plan | 23/05/17 | 23/05/19 | 1,090 sh | $19.59 | $21,353.1 | −25.1% |
Jade BiosciencesJBIO | Open-market sale | 23/04/21 | 23/04/25 | 4,000 sh | $19.50 | $78,000 | −67.1% |